01 4Merck Canada Inc.
01 22133205
02 22573307
01 4Eptifibatide
01 4Solution for Injection
01 42013-04-27
Patent Expiration Date : 2013-04-27
Date Granted : 2007-04-17
Brand Name : INTEGRILIN
Patent Number : 2133205
Filing Date : 1993-04-27
Strength per Unit : 0.75 mg / mL
Dosage Form : Solution for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2013-04-27
Date Granted : 2007-04-17
Patent Expiration Date : 2013-04-27
Date Granted : 2011-01-04
Brand Name : INTEGRILIN
Patent Number : 2573307
Filing Date : 1993-04-27
Strength per Unit : 0.75 mg / mL
Dosage Form : Solution for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2013-04-27
Date Granted : 2011-01-04
Patent Expiration Date : 2013-04-27
Date Granted : 2007-04-17
Brand Name : INTEGRILIN
Patent Number : 2133205
Filing Date : 1993-04-27
Strength per Unit : 2.0 mg / mL
Dosage Form : Solution for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2013-04-27
Date Granted : 2007-04-17
Patent Expiration Date : 2013-04-27
Date Granted : 2011-01-04
Brand Name : INTEGRILIN
Patent Number : 2573307
Filing Date : 1993-04-27
Strength per Unit : 2.0 mg / mL
Dosage Form : Solution for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2013-04-27
Date Granted : 2011-01-04
